{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:07:46Z","timestamp":1789614466060,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"crossref","award":["UL1TR001117"],"award-info":[{"award-number":["UL1TR001117"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences of the NIH","doi-asserted-by":"crossref","award":["UL1TR001117"],"award-info":[{"award-number":["UL1TR001117"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["(HHSN2752010000031"],"award-info":[{"award-number":["(HHSN2752010000031"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["1R01-HD081044-01"],"award-info":[{"award-number":["1R01-HD081044-01"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"Food and Drug Administration","doi-asserted-by":"publisher","award":["1R18-FD005292-01"],"award-info":[{"award-number":["1R18-FD005292-01"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cempra Pharmaceuticals","award":["HHS0100201300009C"],"award-info":[{"award-number":["HHS0100201300009C"]}]}],"content-domain":{"domain":["earlyhumandevelopment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Early Human Development"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.earlhumdev.2015.04.001","type":"journal-article","created":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T02:30:34Z","timestamp":1430188234000},"page":"345-350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Treatment of supraventricular tachycardia in infants: Analysis of a large multicenter database"],"prefix":"10.1016","volume":"91","author":[{"given":"Patricia Y.","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reese H.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Brian Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph P.","family":"Hornik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.earlhumdev.2015.04.001_bb0005","first-page":"167","article-title":"Paroxysmal tachycardia in infants and children: study of 41 cases","volume":"9","author":"Nadas","year":"1952","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2015.04.001_bb0010","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1651-2227.1963.tb03766.x","article-title":"Paroxysmal tachycardia in infancy: a clinical and experimental study","volume":"52","author":"Lundberg","year":"1963","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.earlhumdev.2015.04.001_bb0015","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0002-8703(81)80015-4","article-title":"Electrophysiologic studies of supraventricular tachycardia in children. I. Clinical-electrophysiologic correlations","volume":"102","author":"Garson","year":"1981","journal-title":"Am Heart J"},{"key":"10.1016\/j.earlhumdev.2015.04.001_bb0020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0002-8703(96)90052-6","article-title":"Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants","volume":"131","author":"Weindling","year":"1996","journal-title":"Am Heart J"},{"key":"10.1016\/j.earlhumdev.2015.04.001_bb0025","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0022-3476(97)70037-4","article-title":"Five-year experience with radiofrequency catheter ablation: implications for management of arrhythmias in pediatric and young adult patients","volume":"131","author":"Tanel","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.earlhumdev.2015.04.001_bb0030","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00246-013-0784-3","article-title":"Factors associated with the occurrence and treatment of supraventricular tachycardia in a pediatric congenital heart disease cohort","volume":"35","author":"Tripathi","year":"2014","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.earlhumdev.2015.04.001_bb0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00246-005-1126-x","article-title":"Medications used to manage supraventricular tachycardia in the infant a North American survey","volume":"27","author":"Wong","year":"2006","journal-title":"Pediatr Cardiol"},{"issue":"Suppl. 3","key":"10.1016\/j.earlhumdev.2015.04.001_bb0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/14767058.2010.517937","article-title":"Supraventricular tachycardia in neonates: antiarrhythmic drug choice dilemma","volume":"23","author":"Tavera","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.earlhumdev.2015.04.001_bb0045","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/CIRCEP.112.972620","article-title":"The study of antiarrhythmic medications in infancy (SAMIS): a multicenter, randomized controlled trial comparing the efficacy and safety of digoxin versus propranolol for prophylaxis of supraventricular tachycardia in infants","volume":"5","author":"Sanatani","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.earlhumdev.2015.04.001_bb0050","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/PEC.0b013e3181ce2f6a","article-title":"Intravenous amiodarone used alone or in combination with digoxin for life-threatening supraventricular tachyarrhythmia in neonates and small infants","volume":"26","author":"Dilber","year":"2010","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.earlhumdev.2015.04.001_bb0055","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/CIRCEP.109.901629","article-title":"Amiodarone versus procainamide for the acute treatment of recurrent supraventricular tachycardia in pediatric patients","volume":"3","author":"Chang","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.earlhumdev.2015.04.001_bb0060","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1067\/mhj.2001.111765","article-title":"Amiodarone is safe and highly effective therapy for supraventricular tachycardia in infants","volume":"141","author":"Etheridge","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.earlhumdev.2015.04.001_bb0065","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2459\/JCM.0b013e328329154d","article-title":"Flecainide as first-line treatment for supraventricular tachycardia in newborns","volume":"10","author":"Ferlini","year":"2009","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.earlhumdev.2015.04.001_bb0070","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s00246-011-0010-0","article-title":"High-dose sotalol is safe and effective in neonates and infants with refractory supraventricular tachyarrhythmias","volume":"32","author":"Knudson","year":"2011","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.earlhumdev.2015.04.001_bb0075","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0735-1097(01)01773-9","article-title":"Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1year of age","volume":"39","author":"Price","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.earlhumdev.2015.04.001_bb0080","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00246-012-0474-6","article-title":"A multi-institutional analysis of inpatient treatment for supraventricular tachycardia in newborns and infants","volume":"34","author":"Seslar","year":"2013","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.earlhumdev.2015.04.001_bb0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clp.2010.01.016","article-title":"The Pediatrix BabySteps Data Warehouse and the Pediatrix QualitySteps improvement project system\u2014tools for \u201cmeaningful use\u201d in continuous quality improvement","volume":"37","author":"Spitzer","year":"2010","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.earlhumdev.2015.04.001_bb0090","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1540-8159.2011.03073.x","article-title":"Case fatality in children with supraventricular tachycardia in the United States","volume":"34","author":"Salerno","year":"2011","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.earlhumdev.2015.04.001_bb0095","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/europace\/eut082","article-title":"Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement","volume":"15","author":"Brugada","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.earlhumdev.2015.04.001_bb0100","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jacc.2006.04.091","article-title":"Atrial flutter in infants","volume":"48","author":"Texter","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.earlhumdev.2015.04.001_bb0105","doi-asserted-by":"crossref","first-page":"147R","DOI":"10.1016\/S0002-9149(99)00715-8","article-title":"Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation","volume":"84","author":"Van Gelder","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.earlhumdev.2015.04.001_bb0110","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/PEC.0b013e318032904c","article-title":"Emergency department management of the pediatric patient with supraventricular tachycardia","volume":"23","author":"Manole","year":"2007","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.earlhumdev.2015.04.001_bb0115","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/PCC.0000000000000229","article-title":"Comparative effectiveness of digoxin and propranolol for supraventricular tachycardia in infants","volume":"15","author":"Hornik","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.earlhumdev.2015.04.001_bb0120","author":"Amiodarone IV Label"},{"key":"10.1016\/j.earlhumdev.2015.04.001_bb0125","author":"Amiodarone PO label"},{"key":"10.1016\/j.earlhumdev.2015.04.001_bb0130","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.jacc.2005.06.061","article-title":"Development of a safe and effective pediatric dosing regimen for sotalol based on population pharmacokinetics and pharmacodynamics in children with supraventricular tachycardia","volume":"46","author":"L\u00e4er","year":"2005","journal-title":"J Am Coll Cardiol"}],"container-title":["Early Human Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378215000729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378215000729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T22:50:40Z","timestamp":1537656640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378378215000729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0378378215000729"],"URL":"https:\/\/doi.org\/10.1016\/j.earlhumdev.2015.04.001","relation":{},"ISSN":["0378-3782"],"issn-type":[{"value":"0378-3782","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of supraventricular tachycardia in infants: Analysis of a large multicenter database","name":"articletitle","label":"Article Title"},{"value":"Early Human Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.earlhumdev.2015.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}